التفاصيل البيبلوغرافية
| العنوان: |
What is the role of adipokines in myasthenia gravis? |
| المؤلفون: |
Rozmilowska, Izabela, Czyzewski, Damian, Mazur, Bogdan, Adamczyk-Sowa, Monika |
| المصدر: |
Therapeutics & Clinical Risk Management; Aug2018, Vol. 14, p1515-1525, 11p |
| مصطلحات موضوعية: |
MYASTHENIA gravis, ADIPOKINES, NICOTINIC acetylcholine receptors, ADIPONECTIN, RESISTIN, LEPTIN, PATIENTS |
| مستخلص: |
Objective: Myasthenia gravis (MG) is a disease with autoimmune etiology. The main pathomechanism is related to the production of antibodies against nicotinic acetylcholine receptor. The present study is aimed to compare the serum level of adipokines in patients with MG with that in controls, as well as to study the relation of these levels with disease severity. Patients and methods: Fifty patients with MG and 30 healthy individuals were enrolled in our study. Serum concentrations of select adipokines, namely adiponectin, leptin, omentin, visfatin, and resistin were measured. Results: The results showed a significant increase in serum concentrations of adiponectin and resistin in the patients with MG compared with the controls. Conclusion: Further studies are warranted to assess changes in adipokine concentration levels in patients with MG. [ABSTRACT FROM AUTHOR] |
|
Copyright of Therapeutics & Clinical Risk Management is the property of Dove Medical Press Ltd and its content may not be copied or emailed to multiple sites or posted to a listserv without the copyright holder's express written permission. However, users may print, download, or email articles for individual use. This abstract may be abridged. No warranty is given about the accuracy of the copy. Users should refer to the original published version of the material for the full abstract. (Copyright applies to all Abstracts.) |
| قاعدة البيانات: |
Complementary Index |
Full Text Finder